These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21187187)

  • 1. Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults.
    Rhee EJ; Lee WY; Cho YK; Kim BI; Sung KC
    Am J Med; 2011 Jan; 124(1):69-76. PubMed ID: 21187187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
    Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
    Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The association of cardiovascular risk factors with nonalcoholic fatty liver disease in health checkup examinees].
    Yu JH; Lee KS; Lee SY; Hong AR; Park YS
    J Prev Med Public Health; 2008 Nov; 41(6):407-12. PubMed ID: 19037170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
    Shieh K; Gilchrist JM; Promrat K
    Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
    Fan JG; Li F; Cai XB; Peng YD; Ao QH; Gao Y
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1086-91. PubMed ID: 17608855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.
    Chalasani N; Deeg MA; Persohn S; Crabb DW
    Am J Gastroenterol; 2003 Aug; 98(8):1849-55. PubMed ID: 12907343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.
    Ardigò D; Numeroso F; Valtueña S; Franzini L; Piatti PM; Monti L; Delsignore R; Reaven GM; Zavaroni I
    Metabolism; 2005 Dec; 54(12):1566-70. PubMed ID: 16311087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
    Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
    Metabolism; 2007 Jun; 56(6):792-8. PubMed ID: 17512312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
    Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
    Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronological development of elevated aminotransferases in a nonalcoholic population.
    Suzuki A; Angulo P; Lymp J; St Sauver J; Muto A; Okada T; Lindor K
    Hepatology; 2005 Jan; 41(1):64-71. PubMed ID: 15690483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.
    Bookman ID; Pham J; Guindi M; Heathcote EJ
    Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
    Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
    Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
    Hu ZW; Guo JW; Deng XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of liver fat content to insulin resistance and metabolic syndrome].
    Yan HM; Gao X; Liu M; Gu Q; Zhang B; Li X
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1255-8. PubMed ID: 18844098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
    Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
    Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.